These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17227540)

  • 21. Does methotrexate induce mucosal healing in Crohn's disease?
    Mañosa M; Naves JE; Leal C; Cabré E; Moreno V; Lorenzo-Zuñiga V; Boix J; Domènech E
    Inflamm Bowel Dis; 2010 Mar; 16(3):377-8. PubMed ID: 19575354
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunosuppressed patient becomes pregnant. Termination of pregnancy unavoidable?].
    Stiefelhagen P
    MMW Fortschr Med; 2004 Jul; 146(27-28):12. PubMed ID: 15526652
    [No Abstract]   [Full Text] [Related]  

  • 23. Methotrexate in Crohn's disease.
    Rampton DS
    Gut; 2001 Jun; 48(6):790-1. PubMed ID: 11358896
    [No Abstract]   [Full Text] [Related]  

  • 24. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM; Iser JH; Gibson PR
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of methotrexate in the management of Crohn disease.
    Ravikumara M; Hinsberger A; Spray CH
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):427-30. PubMed ID: 17414138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taking control of Crohn's disease.
    Johns Hopkins Med Lett Health After 50; 2001 Jan; 12(11):3. PubMed ID: 11144610
    [No Abstract]   [Full Text] [Related]  

  • 27. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S; van Assche G; Rutgeerts P
    Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy with methotrexate in paediatric Crohn's disease.
    Kotsiliti E
    Nat Rev Gastroenterol Hepatol; 2023 Jun; 20(6):344. PubMed ID: 37085618
    [No Abstract]   [Full Text] [Related]  

  • 29. JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
    Verbeeck J; Van Assche G; Ryding J; Wollants E; Rans K; Vermeire S; Pourkarim MR; Noman M; Dillner J; Van Ranst M; Rutgeerts P
    Gut; 2008 Oct; 57(10):1393-7. PubMed ID: 18436577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug safety in Crohn's disease therapy.
    Juillerat P; Pittet V; Felley C; Mottet C; Froehlich F; Vader JP; Gonvers JJ; Michetti P
    Digestion; 2007; 76(2):161-8. PubMed ID: 18239408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate Pneumonitis in Crohn's Disease: A Rare Case Report and Review of Literature.
    Sánchez A; Ramírez de la Piscina P; Duca I; Estrada S; Calderón R; Salvador M; Delgado E; García Campos F
    Arch Bronconeumol (Engl Ed); 2018 Oct; 54(10):535-536. PubMed ID: 29503065
    [No Abstract]   [Full Text] [Related]  

  • 32. New therapeutic approaches to Crohn's disease.
    Sartor RB
    N Engl J Med; 2000 Jun; 342(22):1664-6. PubMed ID: 10833215
    [No Abstract]   [Full Text] [Related]  

  • 33. A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease.
    Mansfield JC; Parkes M; Hawthorne AB; Forbes A; Probert CS; Perowne RC; Cooper A; Zeldis JB; Manning DC; Hawkey CJ
    Aliment Pharmacol Ther; 2007 Aug; 26(3):421-30. PubMed ID: 17635377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulation with methotrexate: underused and undervalued?
    Ruemmele FM
    Dig Dis; 2009; 27(3):312-4. PubMed ID: 19786757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
    Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
    Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease.
    Sorrentino D; Terrosu G; Avellini C; Maiero S
    Arch Intern Med; 2007 Sep; 167(16):1804-7. PubMed ID: 17846401
    [No Abstract]   [Full Text] [Related]  

  • 37. Maintenance of medically induced remission of Crohn's disease.
    Gonvers JJ; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Michetti P; Froehlich F
    Digestion; 2007; 76(2):116-29. PubMed ID: 18239403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate for inflammatory bowel disease.
    Guslandi M
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1039. PubMed ID: 23466710
    [No Abstract]   [Full Text] [Related]  

  • 39. [From research to clinic: The case of Crohn's disease and Tumor Necrosis Factor].
    Pellicano R
    Minerva Gastroenterol Dietol; 2000 Jun; 46(2):131-8. PubMed ID: 19320082
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ; Chu XQ; Shi XH; Zhou CL; Seng BW
    J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.